COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine
Huhn, Gregory, Poorbaugh, Josh, Zhang, Lin, Beasley, Stephanie, Nirula, Ajay, Brothers, Jennifer, Welbel, Sharon, Wilson, James, Gillani, Sheena, Weber, Kathleen M, Morack, Ralph, Keckler, Kody, Benschop, Robert J
Published in PloS one (09.09.2022)
Published in PloS one (09.09.2022)
Get full text
Journal Article
Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients
Sims, Jonathan T, Chang, Ching-Yun, Poorbaugh, Josh, Daniels, Montanea, Beasley, Stephanie L, Zhang, Lin, Rodgers, George H, Lena, Fabio, Lacerenza, Leonardo G, Sposato, Bruno, Dupont, Annabelle, Susen, Sophie, Casalini, Giacomo, Corbellino, Mario, Stebbing, Justin, Krishnan, Venkatesh
Published in Journal of translational medicine (08.09.2022)
Published in Journal of translational medicine (08.09.2022)
Get full text
Journal Article
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab
Sims, Jonathan T, Poorbaugh, Josh, Chang, Ching-Yun, Holzer, Timothy R, Zhang, Lin, Engle, Sarah M, Beasley, Stephanie, Doman, Thompson N, Naughton, Lynn, Higgs, Richard E, Kallewaard, Nicole, Benschop, Robert J
Published in Journal of translational medicine (18.03.2022)
Published in Journal of translational medicine (18.03.2022)
Get full text
Journal Article
Evaluation of plasma IL-21 as a potential biomarker for type 1 diabetes progression
Schroderus, Anna-Mari, Poorbaugh, Josh, McElyea, Samantha, Beasley, Stephanie, Zhang, Lin, Näntö-Salonen, Kirsti, Rintamäki, Reeta, Pihlajamäki, Jussi, Knip, Mikael, Veijola, Riitta, Toppari, Jorma, Ilonen, Jorma, Benschop, Robert J, Kinnunen, Tuure
Published in Frontiers in immunology (21.06.2023)
Published in Frontiers in immunology (21.06.2023)
Get full text
Journal Article
Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together
Zhang, Lin, Poorbaugh, Josh, Dougan, Michael, Chen, Peter, Gottlieb, Robert L, Huhn, Gregory, Beasley, Stephanie, Daniels, Montanea, Ngoc Vy Trinh, Thi, Crisp, Melissa, Freitas, Joshua Joaquin, Vaillancourt, Peter, Patel, Dipak R, Nirula, Ajay, Kallewaard, Nicole L, Higgs, Richard E, Benschop, Robert J
Published in Frontiers in immunology (09.12.2021)
Published in Frontiers in immunology (09.12.2021)
Get full text
Journal Article
The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination
Benschop, Robert J, Tuttle, Jay L, Zhang, Lin, Poorbaugh, Josh, Kallewaard, Nicole L, Vaillancourt, Peter, Crisp, Melissa, Trinh, Thi Ngoc Vy, Freitas, Joshua J, Beasley, Stephanie, Daniels, Montanea, Haustrup, Natalie, Higgs, Richard E, Nirula, Ajay, Cohen, Myron S, Marovich, Mary
Published in Science translational medicine (27.07.2022)
Published in Science translational medicine (27.07.2022)
Get more information
Journal Article
146. Intact Sense of Taste and Smell During COVID-19 Infection Is Associated with Absence of of SARS-CoV-2 Spike Protein Antibody Responses within 3 Months of Symptomatic Illness
Wilson, James M, Gillani, Sheena, Bencshop, Robert, Poorbaugh, Josh, Nirula, Ajay, Zhang, Lin, Keckler, Kody, Weber, Kathleen, Morack, Ralph, Beasley, Stephanie, Brothers, Jennifer, Huhn, Gregory
Published in Open forum infectious diseases (04.12.2021)
Published in Open forum infectious diseases (04.12.2021)
Get full text
Journal Article
Level and Duration of IgG and Neutralizing Antibodies to SARS-CoV-2 in Children with Symptomatic or Asymptomatic SARS-CoV-2 Infection
Khaitan, Alka, Datta, Dibyadyuti, Bond, Caitlin, Goings, Michael, Co, Katrina, Odhiambo, Eliud O., Miller, Lucy, Zhang, Lin, Beasley, Stephanie, Poorbaugh, Josh, John, Chandy C.
Published in ImmunoHorizons (01.06.2022)
Published in ImmunoHorizons (01.06.2022)
Get full text
Journal Article
Exclusivity, Labeling Are Sticking Points In Abuse-Deterrence Talks
Get full text
Journal Article
Trade Publication Article
FDA Official: Agency Could Soon Reach ‘Tipping Point’ On Breakthrough Drugs
Get full text
Journal Article
Trade Publication Article
Industry, FDA Debate Safety & Access Issues Not Included In GDUFA Goals
Get full text
Journal Article
Trade Publication Article
Finalized Drug Inspection Refusal Guide Leaves Questions Unanswered
Get full text
Journal Article
Trade Publication Article
OGD Director: FDA On Track To Meet Generic Drug Backlog, Hiring Goals
Get full text
Journal Article
Trade Publication Article
Teva To Submit Third Abuse-Deterrent Hydrocodone NDA By End Of 2014
Get full text
Journal Article
Trade Publication Article
Public Citizen Alleges FDA Is Hiding Opposition To Journal Reprint Guide
Get full text
Journal Article
Trade Publication Article
E&C Republicans Highlight Ebola Dx Shortfalls In Travel Restrictions Push
Get full text
Journal Article
Trade Publication Article
FDA, Industry: Response To Ebola Is Not Replicable For All Rare Diseases
Get full text
Journal Article
Trade Publication Article
Revamped Pfizer Drug Becomes Third FDA-Approved Abuse-Deterrent Opioid
Get full text
Journal Article
Trade Publication Article